Cellular Immunotherapy Global Market 2024 To Reach Xx Billion By 2028 At Rate Of Xx%

Cellular Immunotherapy Market Trends, Strategies, and Outlook by 2024-2033

LONDON, GREATER LONDON, UNITED KINGDOM, September 2, 2024 /EINPresswire.com/ — The cellular immunotherapy market has experienced robust growth in recent years, expanding from $4.99 billion in 2023 to $5.78 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to cancer treatment advancements, clinical success stories, regulatory approvals, growing incidence of targeted diseases.

Strong Future Growth Anticipated
The cellular immunotherapy market is projected to continue its strong growth, reaching $9.95 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to expansion to solid tumors, improved manufacturing, healthcare infrastructure, research funding.

Explore Comprehensive Insights Into The Global Cellular Immunotherapy Market With A Detailed Sample Report:

Growth Driver Of The Cellular Immunotherapy Market
Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases.

Make Your Report Purchase Here And Explore The Whole Industry’s Data As Well:

Major Players And Market Trends
Key players in the cellular immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd., Green Cross Corp.
Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient’s cells, as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast production, and quality control.

Segments:
1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Geographical Insights: North America Leading The Market
North America was the largest region in the cellular immunotherapy market in 2023. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Cellular Immunotherapy Market Definition
Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body’s immune system to combat cancer.

Cellular Immunotherapy Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Cellular Immunotherapy Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cellular immunotherapy market size, cellular immunotherapy market drivers and trends, cellular immunotherapy market major players, cellular immunotherapy competitors’ revenues, cellular immunotherapy market positioning, and cellular immunotherapy market growth across geographies. The cellular immunotherapy market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Drugs for Immunotherapy Global Market Report 202

3D Cell Culture Technologies Global Market Report 2024

Cancer Immunotherapy Global Market Report 2024

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.